IRIS
GERMANI, MASSIMILIANO ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 557
EU - Europa 390
AS - Asia 265
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
Totale 1.220
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 549
CN - Cina 253
IE - Irlanda 139
UA - Ucraina 85
DE - Germania 48
FI - Finlandia 44
SE - Svezia 30
GB - Regno Unito 14
IT - Italia 11
BE - Belgio 8
CA - Canada 8
FR - Francia 8
SG - Singapore 7
BR - Brasile 4
EU - Europa 4
GR - Grecia 2
IL - Israele 2
KR - Corea 2
KZ - Kazakistan 1
NL - Olanda 1
Totale 1.220
Salva come PNG Salva come JPEG
Città #
Dublin 137
Chandler 133
Jacksonville 99
Nanjing 64
Boardman 46
Beijing 43
Ann Arbor 31
New York 30
Nanchang 27
Ashburn 23
Hebei 20
Shenyang 20
Tianjin 19
Princeton 18
Lawrence 17
Medford 14
Wilmington 14
Jiaxing 13
Shanghai 12
Dearborn 11
Helsinki 10
Changsha 9
Hangzhou 9
Woodbridge 9
Brussels 8
Piscataway 6
Los Angeles 5
Toronto 5
Kunming 4
Milan 4
Norwalk 4
Singapore 4
Houston 3
Seattle 3
Verona 3
Zhengzhou 3
Fairfield 2
Netanya 2
Ningbo 2
Washington 2
Winnipeg 2
Amsterdam 1
Changchun 1
Cincinnati 1
Des Moines 1
Fuzhou 1
Grugliasco 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Henderson 1
Lanzhou 1
Lodi Vecchio 1
Pavia 1
Taizhou 1
Walnut 1
Totale 905
Salva come PNG Salva come JPEG
Nome #
A non parametric population approach for selecting biomarkers of a drug action 97
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 87
A Bayesian approach to non-parametric AUC estimation in population studies 82
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 82
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 77
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 77
Modeling myelosuppression in patients treated with anticancer drugs 74
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 73
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 71
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 70
A tumor growth inhibition model in drugs combination regimens 69
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 68
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 67
Statistical methods to detect immune responses to drug administration 64
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts 59
Re: Antitumor Efficacy Testing in Rodents 58
A model based approach to the in vitro evaluation of anticancer activity 53
Totale 1.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 19 1 19 7 22 7 29 22 0
2020/2021156 21 16 4 20 0 20 2 20 4 22 23 4
2021/202283 4 2 5 1 2 0 1 6 3 5 14 40
2022/2023363 34 40 3 25 41 33 1 21 148 3 10 4
2023/2024126 6 7 9 12 5 47 0 10 0 4 8 18
2024/202527 1 20 4 2 0 0 0 0 0 0 0 0
Totale 1.228